Information on autochthonous vectorial transmission of dengue in mainland EU/EEA, including location, period, number of cases, virus serotype and mode of transmission.
Hantavirus infections are widely distributed across Europe, with the exception of some Mediterranean countries which reported a very low number of cases.
Immunisation is the only effective method of prevention. Mumps vaccine is given in the form of the combined trivalent measles-mumps-rubella (MMR) vaccine in all European countries with a first dose at or before 18 months of age. The timing of the second dose varies across countries.
On 14-15 January 2015 an ECDC consultation gathered public health experts, entomologists and epidemiologists from Europe, as well as experts from WHO, CDC and PacNet, to review the EU preparedness to dengue and chikungunya importation and onwards transmission and produce a roadmap towards improved EU preparedness.
ECDC encourages adoption of EU and ISO quality standards for diagnostic and reference laboratory services by its partners in EU laboratory networks and in line with national arrangements and regulations.
ECDC organised a meeting among invited experts to exchange cross-disciplinary perspectives on the issue of MMR vaccination refusal among the general European population.